Gleevec and Lodine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 2 people who take Gleevec and Lodine. Common interactions include depression among females, and chest pain among males.
The phase IV clinical study analyzes what interactions people who take Gleevec and Lodine have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who take Gleevec and Lodine together, and have interactions are studied.
What is Gleevec?
Gleevec has active ingredients of imatinib mesylate. It is used in chronic myelogenous leukemia (cml). Currently, eHealthMe is studying from 35,095 Gleevec users.
What is Lodine?
Lodine has active ingredients of etodolac. It is used in pain. Currently, eHealthMe is studying from 3,827 Lodine users.
Number of Gleevec and Lodine reports submitted per year:
Common Gleevec and Lodine drug interactions by gender *:
female:
- Depression
- Discomfort
- Dyspnoea
- Eye pain
- Malaise
- Muscle spasms
- Nasal congestion
- Oedema peripheral
- Periorbital oedema
- Productive cough
male:
- Chest pain
- Chest tightness
- Dizziness (excl vertigo)
- Flushing
- Sweating increased
Common Gleevec and Lodine drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Chest pain
- Chest tightness
- Dizziness (excl vertigo)
- Flushing
- Sweating increased
* Approximation only. Some reports may have incomplete information.
Do you take Gleevec and Lodine?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Liao KF, Cheng KC, Lin CL, Lai SW, "Etodolac and the risk of acute pancreatitis", BioMedicine, 2017 Jan .
- O'rafferty C, McElligott F, Storey L, O'marcaigh A, Smith O, "Pneumatosis intestinalis and imatinib mesylate", Annals of hematology, 2014 Oct .
Related studies
Drug side effects by duration, gender and age:
- Gleevec side effects (35,095 reports)
- Lodine side effects (3,827 reports)
Common Gleevec drug interactions:
- Gleevec and Aspirin: 964 reports
- Gleevec and Tasigna: 963 reports
- Gleevec and Lasix: 821 reports
- Gleevec and Sprycel: 694 reports
- Gleevec and Lopurin: 655 reports
- Gleevec and Lisinopril: 538 reports
- Gleevec and Omeprazole: 523 reports
- Gleevec and Synthroid: 454 reports
- Gleevec and Prednisone: 443 reports
- Gleevec and Furosemide: 441 reports
Browse interactions between Gleevec and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Lodine drug interactions:
- Lodine and Methotrexate: 337 reports
- Lodine and Prednisone: 302 reports
- Lodine and Aspirin: 279 reports
- Lodine and Prilosec: 270 reports
- Lodine and Neurontin: 234 reports
- Lodine and Lasix: 231 reports
- Lodine and Synthroid: 224 reports
- Lodine and Lipitor: 214 reports
- Lodine and Ultram: 198 reports
- Lodine and Flexeril: 197 reports
Browse interactions between Lodine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on imatinib mesylate and etodolac (the active ingredients of Gleevec and Lodine, respectively), and Gleevec and Lodine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Gleevec and Lodine.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cyclophosphamide and Cardiac Amyloidosis - 4 seconds ago
- Cyclophosphamide and Amyloidosis - Senile - 4 seconds ago
- Imodium and Eosinophilia - 7 seconds ago
- Omeprazole and Pneumonia Staphylococcal - 22 seconds ago
- Colace and Bradycardia - 24 seconds ago
- Prednisone and Eye Infection - 34 seconds ago
- Sertraline and Aphthous Stomatitis - 44 seconds ago
- Azithromycin and Blood Magnesium Decreased - 56 seconds ago
- Verapamil Hydrochloride and Pravachol drug interaction - a minute ago
- Prednisone and Gastroesophageal Reflux Disease - a minute ago